🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 16 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/02/2021 119,02 119,21 114,66 115,41 -3,02% 3,82% 593.800
10/02/2021 115,98 119,99 115,01 119,00 +2,93% 4,29% 753.400
09/02/2021 117,55 117,75 115,28 115,61 -1,72% 2,10% 923.600
08/02/2021 116,74 118,61 115,88 117,63 +1,28% 2,34% 1.247.400
05/02/2021 113,80 118,96 110,18 116,14 +1,39% 7,72% 1.136.300
04/02/2021 113,16 115,59 112,81 114,55 +1,66% 2,46% 818.100
03/02/2021 113,10 115,50 112,34 112,68 -0,67% 2,79% 406.000
02/02/2021 109,29 114,49 106,64 113,44 +7,00% 7,18% 1.063.000
01/02/2021 110,11 110,25 105,31 106,02 -3,40% 4,49% 1.243.100
29/01/2021 111,54 114,07 109,00 109,75 -1,95% 4,55% 816.900
28/01/2021 110,80 113,24 108,36 111,93 +1,02% 4,40% 728.400
27/01/2021 115,24 117,00 110,33 110,80 -4,59% 5,79% 733.700
26/01/2021 119,24 120,01 115,83 116,13 -2,74% 3,51% 1.158.100
25/01/2021 115,75 120,27 115,75 119,40 +2,13% 3,90% 1.138.700
22/01/2021 115,33 117,71 114,09 116,91 +1,66% 3,14% 647.900
21/01/2021 111,47 115,39 110,22 115,00 +3,53% 4,64% 1.289.800
20/01/2021 108,90 111,75 108,01 111,08 +2,11% 3,43% 683.400
19/01/2021 108,37 110,05 107,52 108,78 +1,01% 2,33% 609.000
15/01/2021 108,45 110,52 107,64 107,69 -1,46% 2,66% 610.700
14/01/2021 108,27 110,38 106,00 109,29 +1,05% 4,05% 488.900
13/01/2021 112,80 113,40 105,90 108,15 -3,71% 6,65% 1.551.300
12/01/2021 110,44 113,09 109,90 112,32 +1,83% 2,89% 832.700
11/01/2021 111,11 111,85 107,89 110,30 -1,58% 3,56% 1.261.900
08/01/2021 104,00 113,22 103,53 112,07 +9,00% 9,32% 2.644.500
07/01/2021 97,27 103,56 97,16 102,82 +5,51% 6,58% 1.391.300
06/01/2021 96,23 97,79 95,29 97,45 +0,32% 2,60% 945.000
05/01/2021 95,18 97,42 94,30 97,14 +1,32% 3,28% 464.000
04/01/2021 95,32 96,58 92,71 95,87 +0,02% 4,06% 602.000
31/12/2020 95,70 97,03 93,70 95,85 +0,41% 3,48% 402.900
30/12/2020 94,63 96,57 94,24 95,46 +1,55% 2,46% 642.000